BioDot

Considerations for scaling assays in life science

7 September 2020

As the demand for assay data continues to grow and enabling technology allows us to generate huge datasets at impressive speeds, assay design is as critical as ever says Brian, Kirk, Vice President, Business Development, BioDot. While assay scaling has obvious benefits with respect to data analysis and providing answers to complex questions, scaling a […]